NPM1 and myelodysplastic syndrome: Nowadays, there is no agreement in the literature on whether non-acute NPM1-mutated MNs (NPM1mut-MNs) such as chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with NPM1mut should be diagnosed and treated as AML.